Respiratory guidelines - Which real world?

Annals of the American Thoracic Society

Volumn 11, Issue SUPPL. 2, 2014, Pages

  Wong, Gary W K ^a,b   Miravitlles, Marc ^b,c   Chisholm, Alison ^b   Krishnan, Jerry ^b,d  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b Respiratory Effectiveness Group   (United Kingdom)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d UNIVERSITY OF ILLINOIS HOSPITAL AND HEALTH SCIENCES SYSTEM   (United States)

Author keywords

Guidelines; Observational study; Pragmatic trial; Randomized controlled trial

Indexed keywords

BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST;

ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; COMORBIDITY; CONFERENCE PAPER; HEALTH CARE POLICY; HEALTH INSURANCE; HUMAN; OBSERVATIONAL STUDY; PATIENT CARE; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SECONDARY HEALTH CARE;

EVIDENCE-BASED MEDICINE; HUMANS; OBSERVATIONAL STUDY AS TOPIC; PRACTICE GUIDELINES AS TOPIC; PRAGMATIC CLINICAL TRIALS AS TOPIC; PULMONARY MEDICINE; QUALITY IMPROVEMENT; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84898734264     PISSN: 23256621     EISSN: None     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201309-298RM     Document Type: Conference Paper

References (30)

1. Global Initiative for Asthma website [accessed 2012 August 22]. Available from: http://www.ginasthma.org/Committees
2. Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, et al. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013;187:347-365.
3. Miravitlles M, Soler-Cataluña JJ, Calle M, Molina J, Almagro P, Quintano JA, Riesco JA, Trigueros JA, Piñera P, Simón A, et al. Spanish COPD guidelines (GesEPOC). Pharmacological treatment of stable COPD. Arch Bronconeumol 2012;48:247-257.
4. Harbour R, Miller J. A new system for grading recommendations in evidence based guidelines. BMJ 2001;323:334-336. (Pubitemid 32744465)
5. Schünemann HJ, Oxman AD, Akl EA, Brozek JL, Montori VM, Heffner J, Hill S, Woohead M, Campos-Outcalt D, Alderson P, et al. on behalf of the ATS/ERS ad hoc committee on integrating and coordinating efforts in COPD guideline development. Moving from evidence to developing recommendations in guidelines. An oficial ATS/ERS Workshop report. Proc Am Thorac Soc 2012;9:282-292.
6. Guyatt GH, Oxman AD, Vist G, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schu{combining double grave accent}nemann HJ; GRADE Working Group. Rating quality of evidence and strength of recommendations GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924-926.
7. Roche N, Reddel HK, Martin RJ, Brusselle G, Papi A, Postma D, Thomas V, Rand C, Chisholm A, Price D, et al. Quality standards for real-life research: focus on observational database studies of comparative effectiveness. Ann Am Thorac Soc 2014;11:S99-S104.
8. Qaseem A, Wilt TJ, Weinberger SE, Hannania NA, Criner G, van der Molen T, Marciniuk DD, Denberg T, Schünemann H, Wedzicha W, et al., for the ACCP, the ACP, the ATS and the ERS. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med 2011;155:179-191.
9. Marciniuk DD, Hernandez P, Balter M, Bourbeau J, Chapman KR, Ford GT, Lauzon JL, Maltais F, O'Donnell DE, Goodridge D, et al. Canadian Thoracic Society COPD Clinical Assembly Alpha-1 antitrypsin Deficiency Expert Working Group. Alpha-1 antitrypsin deficiency targeted testing and augmentation therapy: A Canadian Thoracic Society clinical practice guideline. Can Respir J 2012;19:109-116.
10. Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, et al.; Joint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections. Clin Microbiol Infect 2011;17:E1-E59.
11. Woodhead M. New guidelines for the management of adult lower respiratory tract infections. Eur Respir J 2011;38:1250-1251.
12. Rennard S, Thomashow B, Crapo J, Yawn B, McIvor A, Cerreta S, Walsh J, Mannino D. Introducing the COPD Foundation guide for diagnosis and management of COPD, recommendations of the COPD Foundation. COPD 2013;10:378-389.
13. Herland K, Akselsen JP, Skjonsberg OH, Bjermer L. How representative are clinical study patients with asthma or COPD for a larger "real life" population of patients with obstructive lung disease? Respir Med 2005;99:11-19. (Pubitemid 40017378)
14. Rawlins M. De testimonio: on the evidence for decisions about the use of therapeutic interventions. Lancet 2008;372:2152-2161.
15. British Thoracic Society. Scottish Intercollegiate Guidelines Network. Guideline 101. British Guideline on the Management of Asthma. A national clinical guideline 2008 [revised 2012 Jan; accessed 2013 August 22]. Available from: http://www.sign.ac.uk/pdf/sign101.pdf
16. National Heart, Lung, and Blood Institute. The Expert Panel Report 3 (EPR 3): Guidelines for the diagnosis and management of asthma. Bethesda, MD: National Heart, Lung, and Blood Institute; 2007.
17. Lougheed MD, Lemière C, Dell SD, Ducharme FM, Fitzgerald JM, Leigh R, Licskai C, Rowe BH, Bowie D, Becker A, et al. Canadian Thoracic Society Asthma Management Continuum - 2010 Consensus Summary for children six years of age and over, and adults. Can Respir J 2010;17:15-24.
18. Papadopoulos NG, Arakawa H, Carlsen KH, Custovic A, Gern J, Lemanske R, Le Souef P, Mäkelä M, Roberts G, Wong G, et al. International consensus on (ICON) pediatric asthma. Allergy 2012;67:976-997.
19. Bacharier LB, Boner A, Carlsen KH, Eigenmann PA, Frischer T, Götz M, Helms PJ, Hunt J, Liu A, Papadopoulos N, et al.; European Pediatric Asthma Group. Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. Allergy 2008;63:5-34. (Pubitemid 350198248)
20. Travers J, Marsh S, Williams M, Weatherall M, Caldwell B, Shirtcliffe P, Aldington S, Beasley R. External validity of randomised controlled trials in asthma: to whom do the results of the trials apply? Thorax 2007;62:219-223.
21. Costa DJ, Amouyal M, Lambert P, Ryan D, Schünemann HJ, Daures JP, Bousquet J, Bousquet PJ; Lanquedoc-Roussillon Teaching General Practitioners Group. How representative are clinical study patients with allergic rhinitis in primary care? J Allergy Clin Immunol. 2011;127:920-926..e1.
22. Prieto-Centurion V, Rolle AJ, Au DH, Carson SS, Henderson A, Lee TA, Lindenauer PK, McBurnie M, Mularski RA, Naureckas ET, et al. A comparison of three methods used to identify patients with COPD. Am J Respir Crit Care Med 2013;187:A5017.
23. Thorpe KE, Zwarenstein M, Oxman AD, Treweek S, Furberg CD, Altman DG, Tunis S, Bergel E, Harvey I, Magid DJ, et al. A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. CMAJ 2009;180:E47-E57.
24. Price D, Musgrave S, Wilson E, Sims E, Shepstone L, Blyth A, Murdoch J, Mugford M, Juniper E, Ayres J, et al. A pragmatic single-blind randomised controlled trial and economic evaluation of the use of leukotriene receptor antagonists in primary care at steps 2 and 3 of the national asthma guidelines (ELEVATE study). Health Technol Assess 2011;15:1-132.
25. Malmstrom K, Rodriguez-Gomez G, Guerra J, Villaran C, Piñeiro A, Wei LX, Seidenberg BC, Reiss TF. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/ Beclomethasone Study Group. Ann Intern Med 1999;130:487-495. (Pubitemid 29135801)
26. Institute of Medicine. Standards for Developing Trustworthy Clinical Practice Guidelines (CPGs). March 2011. 2011 [accessed 2012 Aug 22]. Available from: http://www.iom.edu/Reports/2011/Clinical-Practice-Guidelines-We-Can-Trust. aspx
27. Price D, Bjermer L, Popov T, Chisholm A. Integrating evidence for managing asthma in patients who smoke. Allergy Asthma Immunol Res (In press).
28. Clatworthy J, Price D, Ryan D, Haughney J, Horne R. Value of self-report assessment of adherence, rhinitis and smoking in relation to asthma control. Prim Care Respir J 2009;18:300-305.
29. Chaudhuri R, Livingston E, McMahon AD, Lafferty J, Fraser I, Spears M, McSharry CP, Thomson NC. Effects of smoking cessation on lung function and airway inflammation in smokers with asthma. Am J Respir Crit Care Med 2006;174:127-133. (Pubitemid 44015385)
30. Chalmers GW, Macleod KJ, Little SA, Thomson LJ, McSharry CP, Thomson NC. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax 2002;57:226-230. (Pubitemid 34214408)